1-54243287-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_145716.4(SSBP3):c.664G>A(p.Gly222Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000651 in 1,613,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145716.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SSBP3 | NM_145716.4 | c.664G>A | p.Gly222Ser | missense_variant | Exon 10 of 18 | NP_663768.1 | ||
SSBP3 | NM_001394360.1 | c.607G>A | p.Gly203Ser | missense_variant | Exon 9 of 17 | NP_001381289.1 | ||
SSBP3 | NM_018070.5 | c.604G>A | p.Gly202Ser | missense_variant | Exon 9 of 17 | NP_060540.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SSBP3 | ENST00000610401.6 | c.664G>A | p.Gly222Ser | missense_variant | Exon 10 of 18 | 5 | ENSP00000479674.2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152054Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000875 AC: 22AN: 251460Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135904
GnomAD4 exome AF: 0.0000677 AC: 99AN: 1461788Hom.: 0 Cov.: 32 AF XY: 0.0000646 AC XY: 47AN XY: 727190
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152054Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74250
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.664G>A (p.G222S) alteration is located in exon 10 (coding exon 10) of the SSBP3 gene. This alteration results from a G to A substitution at nucleotide position 664, causing the glycine (G) at amino acid position 222 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at